跳至主要内容
临床试验/IRCT2016030126860N1
IRCT2016030126860N1已完成未知

The effects of Resveratrol on expression of main ovarian angiogenesis genes (VEGF & HIF-1) & androgene aromatization gene (CYP19) in granolosa cells of PCOS patients and their IVF outcomes.

Tehran University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 40 years(—)
性别
Female

入选标准

  • Inclusion Criteria: Infertility with documented PCOS & Hyperandrogenism; 18-40 Y/O; Candidate for IVF Cycle; If have male factor; it must mild to moderate form, not non-obstructive azospermia; If have other female factor; only cervical & tubal factors are acceptable.

排除标准

  • FSH>10; Severe endometriosis (Stage III or IV); Coshing Syndrome; Hyperprolactinemia; Thyroid diseases; Ovarian Tumors; Severe male factor like non-Obstructive Azospermia; Steroids & OCP taking History in past 3 months; SLE (Systemic Lupus Erythematosus) & autoimmune diseases; Systemic diseases like Metabolic Syndrome, Hyperlipidemia, Diabetes & cardiovascular diseases; Diseases due to malnutrition & obesity with unknown cause.

研究者

相似试验